抗菌药物经济学评价研究进展

Recent Development on Evaluation of Antimicrobial Pharmacoeconomics

目前我国医院临床应用抗菌药物费用不断增长,给社会和病患者带来了沉重的经济负担,开展抗菌药物经济学评价以研究药物治疗方案的成本与效果及其关系是药物经济学评价研究的重要内容。综述近年来国内外抗菌药物经济学评价研究、研究进展与研究的局限性并探讨了抗菌药物个体化给药在感染性疾病治疗的价值与研究的热点。

Antimicrobial agents continue to account for a significant portion of hospital pharmaceutical expenditures, so their use and evaluation for infectious diseases have important economic implications. Economic evaluation of antimicrobial agents is focus on comparing the costs and effects of two or more antimicrobial agents, therapies. Pharmacoeconomic analysis is a valuable tool in accelerating the rational clinical use of antibacterial agents. This article reviews various types of pharmacoeconomic analyses, and examines the current status of the antibacterial pharmacoeconomic literature, including the limitations of pharmacoeconomic analyses. We also discuss the study advancement of antibacterial pharmacoeconomic literature, as well as the value of personalized antimicrobial medicine in economic evaluation of antimicrobial agents.